Početna › Mijelofibroza › Florida
Kliničke studije za Mijelofibroza u državi Florida
14 studija za Mijelofibroza traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04176198A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Florida Cancer Specialist South Reg, Fort Myers
- The Anderson Family Cancer Institute, Jupiter
- Miami NS Ins Baptist Health S FL, Miami
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07357727A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- BRCR Global - Coral Springs, Coral Springs
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07469891A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Advanced Research, LLC, Coral Springs
- Bioresearch Partners, Miami
- AdventHealth - Cancer Institute - Orlando, Orlando
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07623161A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- i još 7
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06661915Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Mayo Clinic Jacksonville, Jacksonville
- Sylvester Cancer Center - U Miami, Miami
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT05320198A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
- Moffitt Cancer Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06343805A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Mayo Clinic-Florida, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07441694Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT05835466A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- University of Miami Health System, Miami
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. tra 2026. · NCT06034002A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Miami, Miami
U tijeku regrutacijaFaza 2
Od 18 do 66 godina · Oba spola · Ažurirano 17. ožu 2026. · NCT06859424SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Mayo Clinic - Jacksonville, Jacksonville
- University of Miami, Miami
- AdventHealth Cancer Institute, Orlando
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2025. · NCT06479135Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.